SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-029251
Filing Date
2022-08-11
Accepted
2022-08-11 16:16:12
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10040603_10q.htm   iXBRL 10-Q 1782829
2 EXHIBIT 10.3 brhc10040603_ex10-3.htm EX-10.3 613259
3 EXHIBIT 31.1 brhc10040603_ex31-1.htm EX-31.1 6296
4 EXHIBIT 31.2 brhc10040603_ex31-2.htm EX-31.2 6208
5 EXHIBIT 32.1 brhc10040603_ex32-1.htm EX-32.1 3738
6 EXHIBIT 32.2 brhc10040603_ex32-2.htm EX-32.2 3678
12 ex10_3image00001.jpg GRAPHIC 21549
13 ex10_3image00002.jpg GRAPHIC 28962
14 logo01.jpg GRAPHIC 6101
  Complete submission text file 0001140361-22-029251.txt   9061407

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA btx-20220630.xsd EX-101.SCH 70804
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE btx-20220630_cal.xml EX-101.CAL 54761
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btx-20220630_def.xml EX-101.DEF 358437
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20220630_lab.xml EX-101.LAB 849452
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20220630_pre.xml EX-101.PRE 508647
74 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040603_10q_htm.xml XML 1266286
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 221156087
SIC: 2834 Pharmaceutical Preparations